What is ABIVAX Société Anonyme's share price today?
ABIVAX Société Anonyme (ABVX) share price today is $86.90 as of October 13, 2026 at 1:30 AM IST. The stock touched a day high of $87.79 and a day low of $86.46.What exchange does ABIVAX Société Anonyme stock trade on, and under what ticker symbol?
ABIVAX Société Anonyme stock trades on PINK under the ticker symbol ABVX.What is ABIVAX Société Anonyme's market capitalization?
ABIVAX Société Anonyme's market capitalization is $7.69B as of October 13, 2026 at 1:30 AM IST.What is ABIVAX Société Anonyme's price-to-earnings (P/E) ratio?
ABIVAX Société Anonyme's price-to-earnings (P/E) ratio is N/A as of October 12, 2026.What is ABIVAX Société Anonyme's price-to-book (P/B) ratio?
ABIVAX Société Anonyme's price-to-book (P/B) ratio is 19.53 as of October 12, 2026.Can Indian investors buy ABIVAX Société Anonyme shares?
Yes, You can buy ABIVAX Société Anonyme shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in ABIVAX Société Anonyme shares from India?
Indian investors can buy ABIVAX Société Anonyme shares in three steps: 1. Search ABIVAX Société Anonyme on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from ABIVAX Société Anonyme shares for Indian investors?
Since ABIVAX Société Anonyme trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in ABIVAX Société Anonyme shares via Tickertape?
Indian investors can start investing in ABIVAX Société Anonyme (ABVX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.115 shares at the current price of $86.90.
Key Metrics
Key Metrics
Close price divided by the earnings per share for the trailing twelve months
Close price divided by the book value per share at the end of the most recent quarter
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
Net profit divided by the total revenue for the most recent financial year
Annual dividend per share for the trailing twelve months divided by the close price
Based on 12 analysts reports
Price Upside
+86.05%
Earnings Growth
+22.76%
Rev. Growth
—
Company Profile
Company Profile
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
All values in $
All values in $
Revenue Forecast
Revenue Forecast
All values in $ Million
All values in $ Million
Earnings Per Share Forecast
Earnings Per Share Forecast
All values in $
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 3.39 | 0 | 7.39 | 0 | 2.01 | 0 | -2.01 | 0 | 0 |
| Gross Profit | - | 3.39 | - | 7.39 | - | 2.01 | - | -3.04 | - | - |
| Net Income | -42.86 | -38.77 | -55.22 | -52.37 | -52.37 | -48.41 | -153.35 | -287.68 | -48.46 | -117.43 |
| Net Profit Margin | - | -1142.67% | - | -707.79% | - | -2400.29% | - | 14263.16% | - | - |
Peers
Peers & Comparison
Peers & Comparison
HealthcareBiotechnology
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| ABIVAX Société Anonyme | - | 19.53 | - |
| AbbVie Inc | 78.09 | 50.45 | 0.54 |
| Amgen Inc | 25.76 | 18.78 | 2.45 |
The 12-month consensus target implies 86.05% growth, versus a trailing 3-year CAGR of 96.60%.